Skip to main content

Iran begins vaccination rollout

Iran has started vaccinating medical workers with the Russian Sputnik V vaccine, but officials say general coverage could take over a year.

TOPSHOT - Iranian health worker Sara Gudarzi receives the COVID-19 vaccine as the country launches its inoculation campain, at the Imam Khomeini hospital in the capital Tehran, on February, 9, 2021. - The inoculation effort for 80-million-plus population is starting with Russia's Sputnik V vaccine, authorities have said, as the novel coronavirus has infected 1.4 million people in Iran and killed more than 58,500, according to the health ministry. (Photo by ATTA KENARE / AFP) (Photo by ATTA KENARE/AFP via Ge
Iranian health worker Sara Gudarzi receives the COVID-19 vaccine as the country launches its inoculation campaign at the Imam Khomeini hospital in the capital Tehran Feb. 9, 2021. — ATTA KENARE/AFP via Getty Images

Iran officially kicked off its long-awaited coronavirus vaccination project Feb. 9 at Tehran’s Imam Khomeini Hospital.

The first stage, according to health officials, will focus on medical staff at intensive care units, where they have been battling the pandemic for more than a year. A second phase, for which a timeline has yet to be specified, is expected to cover all Iranians above the age of 65 as well as those suffering from chronic diseases such as diabetes and high blood pressure.

President Hassan Rouhani had previously described the day as an “auspicious” one for the Iranian nation, promising that nationwide action will be “swift.” He expressed hope that Iran will be better off in its fight against the virus in the coming months.

According to Mostafa Ghanei, a senior member of Iran’s anti-coronavirus task force, the country’s large-scale vaccination project will be conducted with 16 million doses to be purchased from the international COVAX initiative, 25 million through other imports and 25 million doses of multiple vaccines that are being developed domestically. Doses are not slated to start reaching the general public until March 2022. 

SUBSCRIBER EXCLUSIVE

Continue reading this exclusive analysis

Original reporting and analysis unavailable elsewhere. Subscribe to AL-MONITOR to read this story and access everything we publish